AstraZeneca vaccine set to become first to get approval in India-sources reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
India okays Oxford vaccine
WHO grants emergency validation to Pfizer-BioNTech shots
Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken on October 31, 2020. Reuters file photo Agencies Agencies
India s drug regulator yesterday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
The decision clears the vaccine s rollout in the world s second-most populous country which, after the United States, has the highest number of Covid-19 infections.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement.
Britain will only have one million doses of the vaccine at its disposal from Monday
India is set to approve the Oxford-AstraZeneca vaccine today and has already stockpiled 50 million doses - which is 50 times the amount the UK has ready to go.
The coronavirus outbreak in India has so far been less severe in India than in other countries, with an current infection rate of 12 cases per million people compared to the UK s 633 per million.
ADVERTISEMENT
But India s superior manufacturing capacity means that it has been able to produce far more of the Oxford Astrazeneca vaccine in advance, and will soon start inoculating its population of 1.3billion people.
India s drug regulator approves AstraZeneca/Oxford vaccine: sources | The Mighty 790 KFGO kfgo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kfgo.com Daily Mail and Mail on Sunday newspapers.
India drug regulator approves AstraZeneca/Oxford vaccine
01 Jan 2021 The photo has been used for illustrative purposes.
India s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
The decision clears the vaccine s rollout in the world s second-most populous country, which, after the United States, has the highest number of COVID-19 infections.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.